Apr 20

Antimicrobial Stewardship in Aged Care

What Every Infection Control Team Needs to Know

Antimicrobial resistance is not a future threat - it's already happening in your facility. For Infection Control teams in aged care, antimicrobial stewardship (AMS) is one of the most powerful tools you have to protect residents, support safe prescribing, and meet your regulatory obligations in Australia and New Zealand.

Here's what your whole team needs to know.

What Is Antimicrobial Stewardship- and Why Does It Matter in Aged Care?

Antimicrobial stewardship (AMS) is the ongoing effort by a provider and its clinical team to optimise the use of antimicrobial medicines, including antibiotics, antivirals, antifungals, and antiparasitic agents, while minimising their use.
The goal is not to withhold treatment. It's to ensure the right medicine is given to the right resident at the right dose for the right duration.

  • Approximately 50% of antimicrobial prescriptions in Australian residential aged care facilities (RACFs) are deemed inappropriate.
  • Critical antimicrobial resistance (AMR) reports show in Australia, AMR rose 25.2% year on year.
  • Aged care homes are now showing the highest growth in antimicrobial use compared with any other community setting.
  • Inappropriate use drives the development of multidrug-resistant organisms (MDROs) — organisms that are increasingly difficult and costly to treat.



AMS is not a back-of-house compliance exercise. It is front-line resident safety.

Source: Antimicrobial Use in the Community 2024 Report (Australian Commission on Safety and Quality in Health Care [ACSQHC], 2025)

Why Aged Care Residents Are Particularly Vulnerable

Residents in aged care present unique challenges for diagnosing and managing infections. Understanding these vulnerabilities is the first step in responding effectively.

  • typical infection presentations - older adults often don't develop the classic signs of infection (fever, localised pain, raised white cell count). Confusion, reduced appetite, or a fall may be the only indicators.
  • High comorbidity burden and compromised immunity - multiple chronic conditions, polypharmacy, and age-related immune changes make residents both more susceptible to infection and more difficult to assess.
  • Asymptomatic bacteriuria (ASB) over-treatment - bacteria in the urine without symptoms is common in older adults and does not require antibiotic treatment. Yet urine cultures are frequently ordered and, the resident treated with an antibiotic unnecessarily, accelerating resistance.
  • Broad-spectrum antibiotic overuse - when diagnostic uncertainty leads to "cover all bases" prescribing, broad-spectrum agents are used more than necessary, driving MRO development across the entire facility, and not just for the resident receiving the antibiotic.


These vulnerabilities make the Infection Prevention and Control (IPC) Lead's role in AMS not just helpful, but essential.

Sources: ACSQHC Aged Care IPC Guide Version 1.1 (ACSQHC, 2025); Aged Care National Antimicrobial Prescribing Survey (ACQSC, 2024)

The Regulatory Landscape — Australia and New Zealand

Both countries now have clear, binding requirements for AMS in aged care. This is not optional.

Australia
  • Strengthened Aged Care Quality Standards (effective 1 July 2025)- Outcome 5.2 explicitly requires providers to implement a formal AMS system compliant with contemporary, evidence-based practice.
  • The Aged Care Quality and Safety Commission (ACQSC) oversees compliance and has released an AMS Self-Assessment Tool to help facilities review their current activities and identify gaps.
  • The Aged Care National Antimicrobial Prescribing Survey (AC NAPS) - coordinated by the National Centre for Antimicrobial Stewardship (NCAS Australia) - has collected national prescribing data since 2015 and serves as a key quality benchmarking tool.
  • The ACSQHC Aged Care IPC Guide (August 2024, updated January 2025) provides practical implementation support for IPC and AMS.


New Zealand
  • NZS 8134:2021 Ngā Paerewa Health and Disability Services Standard - Part 5 mandates infection prevention and antimicrobial stewardship for all aged care providers.
  • The Health Quality & Safety Commission (HQSC) Te Tāhū Hauora leads the national AMS strategy.
  • The New Zealand Antimicrobial Resistance Action Plan (2017, ongoing) frames the broader national response.
  • AMS and IPC governance now fall under Health New Zealand | Te Whatu Ora.


Sources: Strengthened Aged Care Quality Standards (Department of Health and Aged Care [DoHAC], 2025); NZS 8134:2021 Ngā Paerewa Health and Disability Services Standard (Standards New Zealand, 2021)

Core Elements of an Effective AMS Program in Aged Care

A strong AMS program is multifaceted. No single intervention is sufficient; the evidence consistently shows that combined approaches yield the best outcomes.

Your program should include:
  • Leadership commitment - the governing body, Medical Director, and Director of Nursing must actively champion AMS as an organisational priority, not merely a compliance checkbox.
  • A designated AMS lead, integrated with your IPC system - in most aged care facilities, this will be your IPC lead.
  • Evidence-based prescribing guidelines tailored to aged care - age-specific, locally relevant, and regularly reviewed against local resistance patterns.
  • Standardised infection assessment protocols - including structured clinical assessment tools that reduce diagnostic guesswork.
  • UTI management protocols - implement the "To Dip or Not to Dip" approach to reduce unnecessary dipstick testing and subsequent antibiotic prescribing for asymptomatic bacteriuria.
  • Ongoing staff education - accessible, role-specific, and embedded within orientation and annual competency frameworks.
  • Resident and family engagement - managing expectations about antibiotics is a core AMS function; families need to understand that withholding treatment can sometimes be the safest choice.
  • Surveillance and prescriber feedback - participation in AC NAPS (Australia) provides benchmarking data and supports feedback loops with prescribers.
  • Catheter and invasive device minimisation - indwelling urinary catheters are a major driver of unnecessary antibiotic use; minimise use and review regularly.


Sources: ACSQHC Aged Care IPC Guide Version 1.1 (ACSQHC, 2025); NCAS-Australia Aged Care AMS Resources (NCAS-Australia, 2024)

The Infection Control Team's Role in AMS

AMS and IPC are inseparable in aged care. Your team is uniquely positioned to drive change.

  • Champion AMS at the clinical coalface - you see prescribing patterns, assess residents, and know when something doesn't add up.
  • Lead nurse-driven UTI assessment protocols - research consistently shows that nurse-led UTI management interventions significantly reduce inappropriate antibiotic prescribing.
  • Audit and provide feedback on prescribing data - use AC NAPS or local data to identify patterns, celebrate improvements, and flag concerns to prescribers and the leadership team.
  • Educate your whole team - from enrolled nurses to allied health and housekeeping staff. Everyone has a role in reducing transmission and supporting appropriate treatment decisions.
  • Engage residents and families - your team builds the trust that makes these conversations possible.
  • Liaise with GPs, pharmacists, and pathology - AMS is a multidisciplinary effort; your IPC Lead is the connective tissue linking clinical and prescribing teams.

Practical First Steps for Your Team

If your facility is still building its AMS program, start here:

  • Complete the ACQSC AMS Self-Assessment Tool (Australia) - it's free, structured, and maps directly to Outcome 5.2 compliance requirements.
  • Participate in AC NAPS (Australia) or engage the HQSC AMS resources (New Zealand) - national benchmarking data is one of the most powerful tools for building the case for change with your governing body.
  • Review your UTI management protocol - if it lacks a "To Dip or Not to Dip" decision framework, update it.
  • Put AMS on your governance and quality agenda - it needs a standing agenda item, with metrics, and accountable owners.
  • Access free NCAS-Australia educational resources - practical, evidence-based, and designed for aged care settings.


AMS is one of the clearest examples in aged care where good infection control practice and good clinical care are the same. Your team has the expertise, the relationships, and the influence to make this work. The regulatory expectation is now clear - and so is the clinical case.

Start with the self-assessment. Build from there.

Conclusion

Quick Reference: The "Big Three" for IPC Lead

As a takeaway, focus on these three pillars of AMS.
  1. Regulatory Integration: In Australia, AMS is no longer a "recommendation" but a core requirement under Outcome 5.2. In NZ, it is mandated as part of NZS 8134:2021.
  2. Diagnostic Stewardship: Shifting the focus from "treating the lab result" (such as asymptomatic bacteriuria) to "treating the resident" is the most effective way to reduce inappropriate prescribing rates.
  3. Data as Influence: Using the AC NAPS data isn't just for compliance; it is the evidence the IPC lead needs to have when having difficult conversations with visiting GPs or nurse practitioners about prescribing practices.

Read more of our blogs on the HUB, IPS’s website. Questions? Ask EVE for that quick, nagging question, visit the HUB or contact us at support@infectioncontrol.care

We are on Facebook and LinkedIn – be sure to like and share

Take advantage of our expertise in IPC. See the HUB for policies, resources and courses relating to this very important subject. Ask EVE for a quick answer to your question.